首页 > 最新文献

Clinical Lymphoma Myeloma and Leukemia最新文献

英文 中文
MPN-346 INDEPENDENCE: Enrolling Phase III Trial to Study the Efficacy and Safety of Luspatercept versus Placebo in Patients With Myelofibrosis on JAK2 Inhibitor (JAK2i) Therapy Requiring Red Blood Cell Transfusions (RBCTs) MPN-346独立性:纳入III期试验,研究Luspatercept与安慰剂在需要红细胞输注的JAK2抑制剂(JAK2i)治疗的骨髓纤维化患者中的疗效和安全性
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01234-x
J. Kiladjian, C. Harrison, R. Mesa, H. Al-Ali, J. Mascarenhas, Fabián Sanabria, Julie Vienne Bürki, B. Bengoudifa, F. Passamonti
{"title":"MPN-346 INDEPENDENCE: Enrolling Phase III Trial to Study the Efficacy and Safety of Luspatercept versus Placebo in Patients With Myelofibrosis on JAK2 Inhibitor (JAK2i) Therapy Requiring Red Blood Cell Transfusions (RBCTs)","authors":"J. Kiladjian, C. Harrison, R. Mesa, H. Al-Ali, J. Mascarenhas, Fabián Sanabria, Julie Vienne Bürki, B. Bengoudifa, F. Passamonti","doi":"10.1016/s2152-2650(23)01234-x","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01234-x","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82111541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: CML-640 Case Report of Metachronous Ph+ and Ph Myeloproliferative Neoplasms 海报:CML-640异时性Ph+和Ph骨髓增生性肿瘤病例报告
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00573-6
Kamoliddin Olimjonov, Anna Pirkhalo, E. Efremova, Bekhzodkhon Bakhodirov, E. Iskhakov, V. Shuvaev, I. Martynkevich, Elena Motyko, A. Kirienko, Darya Kustova
{"title":"POSTER: CML-640 Case Report of Metachronous Ph+ and Ph Myeloproliferative Neoplasms","authors":"Kamoliddin Olimjonov, Anna Pirkhalo, E. Efremova, Bekhzodkhon Bakhodirov, E. Iskhakov, V. Shuvaev, I. Martynkevich, Elena Motyko, A. Kirienko, Darya Kustova","doi":"10.1016/s2152-2650(23)00573-6","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00573-6","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78633183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: AML-308 Real-World (RW) Outcomes With Venetoclax (VEN) in Patients With Acute Myeloid Leukemia (AML) From COTA, a US RW Evidence Database 海报:来自美国RW证据数据库COTA的AML-308急性髓性白血病(AML)患者使用Venetoclax (VEN)的真实世界(RW)结果
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00440-8
E. Stein, Sejla Hodzic, Henry F Owusu, Dhrubajyoti Pathak, Summer Zhou
{"title":"POSTER: AML-308 Real-World (RW) Outcomes With Venetoclax (VEN) in Patients With Acute Myeloid Leukemia (AML) From COTA, a US RW Evidence Database","authors":"E. Stein, Sejla Hodzic, Henry F Owusu, Dhrubajyoti Pathak, Summer Zhou","doi":"10.1016/s2152-2650(23)00440-8","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00440-8","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87147729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MDS-044 Cancer Disparities in Survival of Patients With Hematologic Malignancies in the Context of Social Determinants of Health: A Systematic Review 在健康的社会决定因素背景下,血液恶性肿瘤患者生存的癌症差异:一项系统综述
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01162-x
Marisol Miranda-Galvis, K. Tjioe, A. Balas, G. Agrawal, Jorge Cortes
{"title":"MDS-044 Cancer Disparities in Survival of Patients With Hematologic Malignancies in the Context of Social Determinants of Health: A Systematic Review","authors":"Marisol Miranda-Galvis, K. Tjioe, A. Balas, G. Agrawal, Jorge Cortes","doi":"10.1016/s2152-2650(23)01162-x","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01162-x","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87604066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MPN-512 Inpatient Resource Utilization and Costs Associated With Hospitalizations for Thromboembolic Events Among Patients With Polycythemia Vera 真性红细胞增多症患者因血栓栓塞事件住院的住院资源利用和费用
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01249-1
Jingbo Yu, J. Gayle, N. Rosenthal, H. Brown, Evan Braunstein
{"title":"MPN-512 Inpatient Resource Utilization and Costs Associated With Hospitalizations for Thromboembolic Events Among Patients With Polycythemia Vera","authors":"Jingbo Yu, J. Gayle, N. Rosenthal, H. Brown, Evan Braunstein","doi":"10.1016/s2152-2650(23)01249-1","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01249-1","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87987388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ABCL-165 Primary Testicular Diffuse Large B-Cell Lymphoma: Outcome With Uniform Treatment Protocol ABCL-165原发性睾丸弥漫性大b细胞淋巴瘤:统一治疗方案的结果
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01296-x
A. Gogia, Sudhir Kirar, Atul Sharma, Ahit Agni, S. Mallick, Ritu Gupta
{"title":"ABCL-165 Primary Testicular Diffuse Large B-Cell Lymphoma: Outcome With Uniform Treatment Protocol","authors":"A. Gogia, Sudhir Kirar, Atul Sharma, Ahit Agni, S. Mallick, Ritu Gupta","doi":"10.1016/s2152-2650(23)01296-x","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01296-x","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"210 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86247075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: AML-260 A Metabolically Optimized, Non-Cytotoxic Low-Dose Weekly Decitabine/Venetoclax Regimen in MDS and AML 海报:AML- 260a代谢优化,无细胞毒性低剂量每周地西他滨/Venetoclax方案用于MDS和AML
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00432-9
D. Levitz, Kateryna Fedorov, M. Goldfinger
{"title":"POSTER: AML-260 A Metabolically Optimized, Non-Cytotoxic Low-Dose Weekly Decitabine/Venetoclax Regimen in MDS and AML","authors":"D. Levitz, Kateryna Fedorov, M. Goldfinger","doi":"10.1016/s2152-2650(23)00432-9","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00432-9","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82696821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLL-617 Long Term Outcomes and Secondary Malignancies in 673 Patients Treated With Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL) in British Columbia (BC), CanadaElys 加拿大不列颠哥伦比亚省673例口服氟达拉滨和静脉注射利妥昔单抗(FR)治疗慢性淋巴细胞白血病(CLL)患者的CLL-617长期结局和继发恶性肿瘤
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01119-9
E. Vanderveer, Steven J. Huang, H. Bruyèrè, Charles Li, K. Ramadan, D. Villa, D. Scott, K. Savage, J. Connors, L. Sehn, C. Toze, A. Gerrie
{"title":"CLL-617 Long Term Outcomes and Secondary Malignancies in 673 Patients Treated With Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL) in British Columbia (BC), CanadaElys","authors":"E. Vanderveer, Steven J. Huang, H. Bruyèrè, Charles Li, K. Ramadan, D. Villa, D. Scott, K. Savage, J. Connors, L. Sehn, C. Toze, A. Gerrie","doi":"10.1016/s2152-2650(23)01119-9","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01119-9","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"177 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86718901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MDS-156 Pyrimethamine Shows Synergy and Efficacy in Combination With Venetoclax in Preclinical Models of Therapy Resistant MDS/AML MDS-156与Venetoclax联合治疗耐药MDS/AML的临床前模型显示协同作用和疗效
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01168-0
B. Rivera-Peña, S. Chakraborty, Yang Shi, Hui Zhang, Rongbao Zhao, G. Choudhary, Shanisha Gordon-Mitchell, K. Pradhan, Bowen Fu, I. Tošić, C. Schinke, A. Varshavsky, J. Feld, M. Goldfinger, Milagros Carbajal, N. Ramachandra, M. Konopleva, David Frank, Y. Saunthararajah, Amit Verma, A. Shastri
{"title":"MDS-156 Pyrimethamine Shows Synergy and Efficacy in Combination With Venetoclax in Preclinical Models of Therapy Resistant MDS/AML","authors":"B. Rivera-Peña, S. Chakraborty, Yang Shi, Hui Zhang, Rongbao Zhao, G. Choudhary, Shanisha Gordon-Mitchell, K. Pradhan, Bowen Fu, I. Tošić, C. Schinke, A. Varshavsky, J. Feld, M. Goldfinger, Milagros Carbajal, N. Ramachandra, M. Konopleva, David Frank, Y. Saunthararajah, Amit Verma, A. Shastri","doi":"10.1016/s2152-2650(23)01168-0","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01168-0","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"2014 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88961608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: AML-443 Clonal Evolution Analysis Using Next Generation Sequencing (NGS) Panel in a Cohort of 3,025 Patients With Acute Myeloid Leukemia (AML) 海报:在3025例急性髓性白血病(AML)患者队列中使用下一代测序(NGS)面板进行AML-443克隆进化分析
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00460-3
R. Colmenares, C. Sargas, N. Álvarez, M. Chillón, Estrella Carrillo‐Cruz, C. Bilbao-Sieyro, Esther Prados de la Torre, D. Martínez-Cuadrón, R. Rodríguez-Veiga, B. Boluda, C. Gil, T. Bernal, J. Bergua, Lorenzo Algarra, M. Tormo, P. Martínez-Sánchez, E. Soria, J. Serrano, J. Alonso‐Dominguez, R. García-Boyero, M. Amigo, Pilar Herrera-Puente, M. Sayas, Esperanza Lavilla-Rubira, M. Calasanz, R. García-Sanz, J. Pérez-Simón, M. Gomez-Casares, J. Sánchez‐García, E. Barragán, J. Martínez-López, P. Montesinos
{"title":"POSTER: AML-443 Clonal Evolution Analysis Using Next Generation Sequencing (NGS) Panel in a Cohort of 3,025 Patients With Acute Myeloid Leukemia (AML)","authors":"R. Colmenares, C. Sargas, N. Álvarez, M. Chillón, Estrella Carrillo‐Cruz, C. Bilbao-Sieyro, Esther Prados de la Torre, D. Martínez-Cuadrón, R. Rodríguez-Veiga, B. Boluda, C. Gil, T. Bernal, J. Bergua, Lorenzo Algarra, M. Tormo, P. Martínez-Sánchez, E. Soria, J. Serrano, J. Alonso‐Dominguez, R. García-Boyero, M. Amigo, Pilar Herrera-Puente, M. Sayas, Esperanza Lavilla-Rubira, M. Calasanz, R. García-Sanz, J. Pérez-Simón, M. Gomez-Casares, J. Sánchez‐García, E. Barragán, J. Martínez-López, P. Montesinos","doi":"10.1016/s2152-2650(23)00460-3","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00460-3","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90224751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Lymphoma Myeloma and Leukemia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1